CN | EN
Specializing in molecular-specific analysis to safeguard innovative drug research and development
About  us
Platform advantages
Development history
Partners
ShownBio is a leading biotechnology company specializing in antibody specificity analysis . Since the company was founded in 2019, ShownBio independently constructed 6100+ plasma membrane proteins , established an automated, high-throughput detection platform, created a data visualization, traceable quality system, and created an internationally leading protein specific verification platform, which can provide "one-stop, integrated" protein non-specific screening services. The specificity verification platform includes 5 functional modules and 5 platforms, which provide systematic solutions for drug safety evaluation, provide theoretical basis for the study of virus mechanism, and provide scientific research ideas for ligand receptor orphaning. Provide design support for drug development and provide new possibilities for target discovery.
ABOUT US
PLATFORM ADVANTAGES
Pioneering ability

In‑house‑built proprietary platform

First domestic offering for external services

Short assay turnaround time

High sperm testing

Automated high‑throughput experimental system

Minimal background interference

Superior detection sensitivity

Compliance Quality Control

Data visualization capability

Traceable quality system

Rich project references

Support for CDE & FDA regulatory submissions

Platform Consistency

Benchmark against in‑vivo action profiles of real‑world drugs

Completed off‑target studies of multiple marketed mAbs

Case references covering camrelizumab, rituximab, etc.

Risk Preemption

Identify drug off‑target risks at pre‑research stage

Proactively mitigate potential safety concerns

Reduce investment risks in R&D and clinical phases

DEVELOPMENT HISTORY
PARTNERS
  • 70+
    Cooperative customers
  • 3cases
    Agency
  • 500+
    Cases
  • 18cases
    Successful IND Filing Cases in China and the US